In Alnylam’s Search For A Mass-Market Treatment, A Twice Yearly Blood Pressure Injection Could Fit The Bill

Crucial Phase II Readouts This Year

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.